News |  Disclaimer |  Contact |  Sitemap |  Privacy Notice | 
About us  |   Business Development  |   Territories  |   Partners  |  
Ewopharma launches state-of-the-art iron therapy from Pharmacosmos

Ewopharma entered into a new partnership with Pharmacosmos, a leading specialist in intravenous iron therapy with innovative pharmaceutical products to replenish body iron stores in patients with iron deficiency anemia.

In Bulgaria, Ewopharma has taken over the responsibility for Cosmofer, a parenteral iron formulation of low molecular weight iron dextran. This product is mainly used for adult patients with chronic kidney disease. To date, more than 70 million doses of Cosmofer have been administered.

In April 2012, Ewopharma will launch Monofer in Bulgaria and Romania. Monofer is the state-of-the-art intravenous iron product (iron isomaltide 1000), which allows to treat patients with iron deficiency anemia in one rapid visit. Thus, new patient groups where oral iron preparations are ineffective or cannot be used, or where there is a clinical need to deliver iron rapidly can receive a targeted treatment.